Association of MAGEA4 expression with molecular and immune subtypes and clinical outcomes in recurrent bladder cancer. Luo H, Xu C, Liu Y, Yao Y, et al. Front Oncol 2026;16:1906141.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Luo H, Xu C, Liu Y, Yao Y, et al. Association of MAGEA4 expression with molecular and immune subtypes and clinical outcomes in recurrent bladder cancer. Front Oncol 2026;16:1906141.
PMID: 42959047